Strength Seen in LivaNova (LIVN): Can Its 12.7% Jump Turn into More Strength?Zacks Investment Research • 04/18/23
LivaNova (LIVN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 03/15/23
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass ProceduresBusiness Wire • 03/09/23
Down -12.75% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)Zacks Investment Research • 02/28/23
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass ProceduresBusiness Wire • 02/08/23
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug AdministrationBusiness Wire • 12/13/22
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual MeetingBusiness Wire • 11/30/22
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support SystemBusiness Wire • 11/17/22
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare ConferencesBusiness Wire • 11/08/22
LivaNova (LIVN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/26/22